Foundation for
|
|
![]()
The Foundation for Applied Research in Gastrointestinal Oncology (FARGO) is a
non-profit 501 (c)(3) organization that promotes
research, education and patient care in gastrointestinal oncology.
|
Paul
Sugarbaker, M.D. Renaldo Savady, M.D. |
President
Secretary-Treasurer
|
A major goal of
A Message From
the President of
Again, 2007 FARGO initiatives reached new plateaus. The concept of peritoneal surface malignancy as a condition with curative treatment options has emerged for the medical oncologist, gastroenterologist and surgeon. New peritoneal surface malignancy treatment centers are being organized on a monthly basis throughout the USA, Europe, Eastern Europe and Asia. Protocols to extend cytoreductive surgery and perioperative intraperitoneal chemotherapy to ovarian cancer have been initiated at several institutions including Johns Hopkins Hospital and Memorial Sloan-Kettering Cancer Center.
Prospective multi-institutional standardized clinical pathways with pooled data management and reporting are increasingly difficult (IRB and HIPAA regulations). However, further international collaborative efforts need to be initiated in colon cancer, gastric cancer, and now extended into ovarian cancer. Although reimbursement issues continue to be a barrier to full utilization, the medical politics blocking an attack on peritoneal surface dissemination seems to have markedly decreased.
Our
The Foundation for Applied Research in Gastrointestinal Oncology (FARGO) is
a non-profit 501 (c)(3) organization that is intended
to promote research, education, and patient care in gastrointestinal cancer.